Think Long Term and Win Big with Small Biotechs: Hugh Cleland

By International Business Times August 09, 2012, 03:49:04 PM EDT

Think Long Term and Win Big with Small Biotechs: Hugh Cleland

Source: George S. Mack of The Life Sciences Report   (8/9/12)

http://www.thelifesciencesreport.com/pub/na/14076

BluMont Capital Portfolio Manager Hugh Cleland has taken a venture capital and private equity approach to investing in public companies, some of which have penny-stock market caps in the $5-15 million range. The idea is to invest in small- and micro-cap stocks without facing redemption risk, and to employ a hands-on approach when helping innovative companies create and realize value over the long term. In this way time becomes the friend-not the enemy-of companies looking for scarce capital in a risk-averse world. In this exclusive interview with The Life Sciences Report , Cleland shares the names of a handful of small companies that could return tenfold or greater multiples to investors.

Read More on International Business Times




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Commodities

Referenced Stocks: APO



Latest News Video



From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.51 0.08  0.60%
RAD $ 2.80 0.01  0.36%
CSCO $ 23.94 0.30  1.24%
MSFT $ 35.06 0.19  0.54%
WCRX $ 19.60 0.39  2.03%
SIRI $ 3.49 0.01  0.29%
FB $ 25.76 0.49  1.87%
S $ 7.29 0.03  0.41%